Georgia's Online Cancer Information Center

Harvey Hamrick

Harvey James Hamrick, MD, MPH

Vice President, Clinical Oncology

Flatiron Health

Harvey James Hamrick, MD, MPH

Harvey Hamrick

Vice President, Clinical Oncology

Flatiron Health

James Hamrick is a board certified Medical Oncologist and Hematologist and health tech thought leader. He leads the team of doctors, nurses, and informatics specialists who inform the development and applications of the Flatiron products and services relied upon by front-line clinicians in hundreds of cancer clinics across the United States and has extensive speaking experience in key Oncology and health technology forums. 

James joined Flatiron from Kaiser Permanente of Georgia in 2016, where he served as Chief of Medical Oncology and Hematology. Prior to that he practiced at Georgia Cancer Specialists. This is his second term on the board of the Georgia Center for Oncology Research and Education, and he previously served on the Kaiser Permanente National Inter-Regional Cancer Leadership Council and the KP National Cancer Chiefs Council.

James received his MD and an MPH in epidemiology from the University of North Carolina at Chapel Hill. He completed his residency and hematology/oncology fellowship at the University of California San Francisco.

About Us

Georgia CORE announces the first annual Phillip H. Street Cancer Community Service Award and the 2023 Matt Mumber M.D. Award for Excellence in Cancer

After a months-long nomination and selection process, Georgia CORE is pleased to announce Tiah Tomlin-Harris the winner of the first award given in honor of the late Phillip Street. Together with CPNG, Georgia CORE also has awarded the 2023 Matt Mumber M.D. Award for Excellence in Cancer Patient Navigation to Emily Beard of Northside Hospital


Looking Across Disciplines to Share the Breadth of Innovation in Cancer Care

On July 25, 2023, The American Journal of Managed Care® brought its Institute for Value-Based Medicine (IVBM) series to Atlanta, Georgia, where nnovation was on the agenda.


DNA sequencing can lead to longer, better lives for cancer patients. But why do so few get it?

Guidelines now call for everyone diagnosed with advanced lung and colon cancer to get their tumor genetically sequenced, and increasingly, patients with earlier stage disease, as well.


Georgia CORE releases report from Disparities in Cancer Clinical Trials Summit

On Sept. 30, Georgia's cancer experts shared advice and experiences with oncology providers, patient navigators and research managers - all to provide new ways to diversify participation in clinical trials. In February 2023, Georgia CORE issued a report with a recap and actions steps. Download the report >>


Georgia CORE


Advancing Cancer Care through Partnerships and Innovation

Georgia CORE is a statewide nonprofit that leverages partnerships and innovation to attract more clinical trials, increase research, and promote education and early detection to improve cancer care for Georgians in rural, urban, and suburban communities across the state.